Skip to main content
Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
7.76
+0.06 (0.78%)
At close: Nov 13, 2026, 4:00 PM EST
7.55
-0.21 (-2.71%)
After-hours: Nov 13, 2026, 7:30 PM EST

Avalo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-88.65-78.26-35.13-31.54-41.66-84.38
Depreciation & Amortization
0.070.340.170.160.171.66
Other Amortization
---1.831.390.79
Asset Writedown & Restructuring Costs
--27.643.91--
Loss (Gain) From Sale of Investments
-1.44-0.69----
Stock-Based Compensation
18.6113.625.853.487.558.17
Other Operating Activities
-2.919.69-42.880.735.860.02
Change in Accounts Receivable
----1.061.12
Change in Inventory
---0.020.02-0.04
Change in Accounts Payable
1.98-0.15-0.16-2.44-0.490.8
Change in Unearned Revenue
----0.090.09-
Change in Other Net Operating Assets
8.883.99-4.55-6.74-0.740.96
Operating Cash Flow
-63.47-51.46-49.06-30.68-26.75-70.89
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.16-0.1-0.11
Sale of Property, Plant & Equipment
---0.03--
Cash Acquisitions
--0.36---
Investment in Securities
-313.25-81.72----
Investing Cash Flow
-313.25-81.720.36-0.13-0.1-0.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----32.9
Long-Term Debt Repaid
----21.24-14.81-
Net Debt Issued (Repaid)
----21.24-14.8132.9
Issuance of Common Stock
442.4815.56185.0746.290.1173.86
Repurchase of Common Stock
-0.78-0.51----
Other Financing Activities
-26.87-0.46-9.22---
Financing Cash Flow
414.8414.59175.8525.04-14.7106.76

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
38.12-118.59127.15-5.77-41.5535.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-63.47-51.46-49.06-30.84-26.85-71.01
Free Cash Flow Growth
------
Free Cash Flow Margin
-107569.49%-87216.95%-11123.81%-1602.81%-148.72%-1315.39%
Free Cash Flow Per Share
-1.85-3.84-6.54-111.04-684.81-1961.95
Levered Free Cash Flow
-19.38-17.26-16.08-17.49-12.04-37.89
Unlevered Free Cash Flow
-19.38-17.26-16.08-17.18-10.82-37.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---1.932.931.59
Change in Working Capital
10.863.84-4.71-9.24-0.062.84
SEC Filings: 10-K · 10-Q